BEQVEZ DIN 02544156
Health Canada record
| Active ingredient(s) | FIDANACOGENE ELAPARVOVEC 10000 BVG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | SCHEDULE D; PRESCRIPTION |
| Class | Human |
| ATC | B02BD17 FIDANACOGENE ELAPARVOVEC |
| Original market date | |
| Current status date | 10-Jun-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 32406 | 2023-12-27 | New Drug Submission (NDS) |